market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Figs, the most common co-covered peer. Each story carries 6 original sources on average, compared with 4 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Progyny
market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Figs, the most common co-covered peer. Each story carries 6 original sources on average, compared with 4 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.7 for that window. Progyny appears in 1 tracked Healthcare story from February 25, 2026.
Stories tracked
1
Sources per story
6
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Progyny. Shared-story counts are live from our verified record — not editorial picks.
A wave of Q4 earnings previews highlights critical performance metrics for healthcare-adjacent firms, including fertility benefits leader Progyny and medical apparel disruptor Figs. Investors are specifically watching for signs of sustained consumer demand and the operational impact of AI integration across these diverse platforms.
Progyny is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.